Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. 24HrDoc, Inc. dba 24HrDoc
WARNING LETTER
•24HrDoc, Inc. dba 24HrDoc•December 31, 2025

24HrDoc, Inc. dba 24HrDoc – FDA Warning Letter, Dec 31, 2025

Record Details

The FDA issued a Warning Letter to 24HrDoc, Inc. dba 24HrDoc on February 20, 2026, following a December 2025 review of its website. The letter identified significant violations concerning compounded drug products, specifically semaglutide and tirzepatide. The primary issues involve misbranding under the Federal Food, Drug, and Cosmetic Act (FDCA). 24HrDoc"s website falsely implied it was the compounder of these drugs by displaying "24HrDoc" on product labels. Additionally, the company made misleading claims such as "Same ingredients as: Ozempic and Wegovy" and "Same ingredients as: Mounjaro and Zepbound," suggesting FDA approval or evaluation for safety and effectiveness, which is not true for compounded drugs. These actions violate FDCA sections 502(a) and 502(bb) regarding false or misleading labeling and advertising, and section 301(a) for introducing misbranded products into interstate commerce. 24HrDoc is required to take immediate corrective action. Within 15 working days, they must provide a written response detailing steps taken to address violations, including identifying actual compounders, providing labeling samples, and modifying or removing all false or misleading website claims. Failure to comply could lead to further legal action.

Company
24HrDoc, Inc. dba 24HrDoc
Inspection date
December 31, 2025
Product type
drugs
Office
Center for Drug Evaluation and Research
Person
  • Matthew J. Lash (Acting Director)
View Company Profile

ID · b4fdaa8e-0948-4cb0-b285-ec078126cf83

Violation Codes10
21 U.S.C. 321(p)21 U.S.C. 331(c)FD&C Act 503AFD&C Act 201(g)21 CFR 201.61(a)FD&C Act 503B(A)(10)(A)(i)FD&C Act 301(c)21 U.S.C. 352(a)FD&C Act 503(b)FD&C Act 201(p)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore 24HrDoc, Inc. dba 24HrDoc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.